✦ LIBER ✦

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial

✍ Scribed by Manuela Schmidinger; Alexandra C. Budinsky; Catharina Wenzel; Gottfried J. Locker; Ursula Pluschnig; Thomas Brodowicz; Ernst Kubista; Sylvia Maca; August Zabernigg; Peter Ilsinger; Lothar Seewann; Sabine Hojas; Michaela Blach; Christoph C. Zielinski; Guenther G. Steger

Publisher: Springer
Year: 2000
Tongue: English
Weight: 99 KB
Volume: 47
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel administration on days 1 and

Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial

✍ M. Donadio; E. Manzin; A. Berruti; A. Bottini; G. Gorzegno; S. Danese; E. DeFabi 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 92 KB

Concomitant docetaxel plus gemcitabine v

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

✍ Antoaneta Tomova; Rupert Bartsch; Thomas Brodowicz; Valentina Tzekova; Constanta 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 277 KB